Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × Aggression × Clear all

Phase

Phase 2 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1127 Breast Neoplasms 582 Carcinoma, Non-Small-Cell Lung 440 Lymphoma 375 Neoplasm Metastasis 366 Leukemia, Myeloid, Acute 360 Melanoma 337 Prostatic Neoplasms 316 Multiple Myeloma 312 Lymphoma, Non-Hodgkin 300 Ovarian Neoplasms 288 Pancreatic Neoplasms 274 Colorectal Neoplasms 270 Precursor Cell Lymphoblastic Leukemia-Lymphoma 268 Leukemia, Lymphocytic, Chronic, B-Cell 268 Leukemia 243 Unspecified Adult Solid Tumor, Protocol Specific 230 Lung Neoplasms 224 Glioblastoma 222 Recurrence 215 Lymphoma, Follicular 205 Brain Neoplasms 203 Lymphoma, Large B-Cell, Diffuse 200 Lymphoma, Mantle-Cell 171 Head and Neck Neoplasms 161 Hodgkin Disease 159 Carcinoma, Renal Cell 159 Myelodysplastic Syndromes 156 Glioma 144 Colonic Neoplasms 144

Interventions

selinexor 1 Rituximab 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡